Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression

BACKGROUND. To investigate post-treatment changes in serum testosterone in low- and intermediate-risk prostate cancer patients treated with hypofractionated passively scattered proton radiotherapy. MATERIAL AND METHODS. Between April 2008 and October 2011, 228 patients with low- and intermediate-ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Kil, Whoon Jong, Nichols, Romaine C., Hoppe, Bradford S., Morris, Christopher G., Marcus, Robert B., Mendenhall, William, Mendenhall, Nancy P., Li, Zuofeng, Costa, Joseph A., Williams, Christopher R., Henderson, Randal H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Informa Healthcare 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613975/
https://www.ncbi.nlm.nih.gov/pubmed/23477360
http://dx.doi.org/10.3109/0284186X.2013.767983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613975/
https://www.ncbi.nlm.nih.gov/pubmed/23477360
http://dx.doi.org/10.3109/0284186X.2013.767983

Ejemplares similares